<DOC>
	<DOCNO>NCT00505531</DOCNO>
	<brief_summary>The Massachusetts General Hospital Center Translational Pain Research conduct research study see Ultram ER , FDA-approved pain medication , would helpful provide pain relief subject whose chronic pain well control narcotic pain medicine .</brief_summary>
	<brief_title>Pain Study See Ultram ER Will Provide Relief Subjects Whose Pain Not Well Controlled Narcotics</brief_title>
	<detailed_description>The study consist 6 visit 6 week . Study test include : physical exam , urine testing , questionnaires non-invasive ( needle ) nerve test use cold/heat sensation . Compensation park reimbursement provide .</detailed_description>
	<mesh_term>Chronic Pain</mesh_term>
	<mesh_term>Narcotics</mesh_term>
	<criteria>1 . Subject age 18 65 year three group . 2 . Subject NOT Tramadol Tramadol ER least one month . 3 . Subject NOT tricyclic antidepressant , serotonin , norepinephrine , mixed serotonin/norepinephrine reuptake inhibitor ( SSRI/SNRI ) , muscle relaxant potential action SSRI SNRI ( e.g. , Flexeril ) least one month . Subject monoamine oxidase inhibitor past 14 day . 4 . Subjects stable pain condition ( e.g. , axial low back pain listed item # 57 ) least three month . This requirement set order avoid clinical uncertainty unstable pain condition minimize study variation . 5 . Axial low back pain refers pain condition result myofascial disorder , lumbar facet joint disease , discogenic disease , postlaminectomy syndrome . Patients neurological sign ( weakness numbness ) include study potential confounding effect QST assessment pain threshold pain tolerance . 6 . Headaches refer migraine , tension , cluster headache , cervicogenic pain ( e.g. , facet joint disease , myofascial pain ) , trigeminal neuralgia . However , patient neurological disease include multiple sclerosis , amyotrophic lateral sclerosis , stroke include due possible neurological deficit may confound QST assessment . 7 . Abdominal pelvic pain refers pain abdominal and/or pelvic organ ( e.g. , chronic pancreatitis , endometriosis ) . 8 . Subject willing his/her opioid dose taper . 9 . Female subject childbearing potential must negative urine pregnancy test initial visit . 1 . Subject sensory deficit site QST . Sensory deficit refer change result neurological disease medical condition cause peripheral polyneuropathy sensory change , include limited diabetes , alcoholic neuropathy , AIDS neuropathy , thyroid disease , severe liver kidney disorder . 2 . Subject scar tissue , infection , acute injury site QST . 3 . Subject interventional procedure may alter result QST . Such procedure include neuroablation ( chemical electrothermal ) time , neuraxial ( e.g. , epidural ) local anesthetic block within last eight week , lumbar sympathetic hypogastric block within last six month . We consider eight week six month minimal time period must elapse neuraxial injection lumbar sympathetic block , respectively , order minimize possible influence previous interventional procedure . 4 . Subject pending litigation relate his/her chronic pain condition . 5 . Subject history current seizure disorder . 6 . Subject history severe allergic reaction Tramadol ER opioid medication . 7 . Subject major psychiatric disorder ( major depression ; bipolar disorder ; schizophrenia ; anxiety disorder ; psychotic disorder ; eat disorder ; alcohol drug dependence ; attention deficit hyperactivity disorder ) ; subject know history condition also exclude . 8 . Subject severe renal impairment severe hepatic impairment . 9 . Subject use illicit drug detect urine toxicology screen . 10 . Subject pregnant lactating .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>July 2014</verification_date>
	<keyword>Pain</keyword>
</DOC>